Study of LEAP2 on eating control during semaglutide treatment
Part of Hormones & metabolism clinical trials.
This study looks at how a natural hormone called LEAP2 affects your appetite and eating behavior while you are taking semaglutide (a weight loss medicine). The results might help doctors understand how to make weight loss treatments even better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Between 18 and 65 years old
- Body mass index (BMI) of 25 or higher
- Currently taking semaglutide (≥1 mg weekly) for at least 3 months and weight stable (±3% in last 3 months)
- No diabetes (type 1 or 2) and no diabetes medication (other than semaglutide)
- No anemia, liver, kidney, or serious stomach/gut problems
- No regular tobacco or nicotine use; not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study looks at how genetic factors may change how people respond to a GLP-1 medicine (semaglutide). The goal is to learn who may benefit most and why, so future treatments can be better matched.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study looks at how semaglutide (a medication for type 2 diabetes or weight management) affects your heart, kidneys, and overall metabolic health over time. It uses medical records from LMC endocrinology clinics to track real-world outcomes.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
Hear when a new Obesity &Amp; Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.